Tag: capital

卡爾霍恩，喬治亞州, July 26, 2025 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc.（NYSE: MHK）今天宣布 2025 年第二季度淨盈利為 1.47 億美元，每股盈利（「EPS」）為 2.34 美元；調整後淨盈利為 1.73 億美元，調整後每股盈利為 2.77 美元。 2025 年第二季度報告淨銷售額為 28 億美元，與去年相比基本持平，按固定天數和匯率調整後與去年相比下降了 0.8%。 在 2024 年第二季度，公司報告淨銷售額為 28 億美元，淨盈利為 1.57 億美元，每股盈利為 2.46 美元；調整後淨盈利為 1.92 億美元，而調整後每股盈利則為 3.00 美元。

KUALA LUMPUR, Malasia, July 25, 2025 (GLOBE NEWSWIRE) -- Bitget, la principal bolsa de criptomonedas y empresa Web3, participó en la Malaysia Blockchain Week 2025 (la Semana de las Cadenas de Bloques de Malasia 2025), para consolidar sus vínculos con la economía digital en rápido crecimiento del Sudeste Asiático. Celebrado en el World Trade Centre de Kuala Lumpur, el evento reunió a más de 3.300 participantes de 20 países, y contó con el apoyo de agencias malasias como MDEC, el Ministerio de Tecnologías Digitales y el Ministerio de Turismo de Malasia.

KUALA LUMPUR, Malaisie, 26 juill. 2025 (GLOBE NEWSWIRE) -- Bitget, première bourse de cryptomonnaies et société Web3 au monde, a participé à la Malaysia Blockchain Week 2025 en vue de renforcer ses liens avec l’économie numérique florissante de l’Asie du Sud-Est. Organisé au World Trade Centre de Kuala Lumpur, l’événement a attiré plus de 3 300 participants venus de 20 pays, avec le soutien d’agences malaisiennes telles que MDEC, le ministère du Numérique et Tourism Malaysia.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Caribou (CRBU) To Contact Him Directly To Discuss Their Options

SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution (“IDR”) vendor HaloMD.

New York, July 25, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") for its client Garden Stage Limited (NASDAQ: GSIW) (“GSIW” or the “Company”), a Hong Kong-based financial services provider.

Investors can contact the law firm at no cost to learn more about recovering their losses

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, announced today that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-12 (the “Reverse Stock Split”). The Company’s common stock is expected to commence trading on a split-adjusted basis when the NYSE American market opens on August 5, 2025 under the existing symbol of “CLDI.” The new CUSIP number for the Company’s common stock following the Reverse Stock Split will be 320703 408.

CORYDON, Ind., July 25, 2025 (GLOBE NEWSWIRE) -- First Capital, Inc. (the “Company”) (NASDAQ: FCAP), the holding company for First Harrison Bank (the “Bank”), today reported net income of $3.8 million, or $1.13 per diluted share, for the quarter ended June 30, 2025, compared to net income of $2.8 million, or $0.85 per diluted share, for the quarter ended June 30, 2024.

GEELONG, Australia, July 25, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that Orion Infrastructure Capital ("OIC") has released US$5 million of the US$25 million facility announced on December 23, 2024. As a result of this release, the full US$25 million facility has now been released. Concurrent with this US$5 million tranche, lenders under the US$60 million PIUS loan entered into in May 2023 (“Existing Noteholders”) have also released the final US$400,000 of existing loan reserves, taking reserves released to US$2 million. In connection with this funding tranche, the Company will issue to OIC and Existing Noteholders, penny warrants to purchase an aggregate number of shares equal to 5.0% of the Company’s shares outstanding.

SOUTH SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- Recognify Life Sciences, a clinical-stage biotech company focused on developing treatments for cognitive impairment, today announced that its randomized, double-blind, placebo-controlled Phase 2b clinical trial evaluating inidascamine (formerly RL-007) in patients with cognitive impairment associated with schizophrenia (CIAS) did not meet its primary endpoint.